Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares U.S. Pharmaceuticals ETF (IHE)

151.23
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
135.09
Today|||52-Week Range
161.20
+6.94%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines- but excludes producers of vitamins. The fund is non-diversified.

Pharma ETFs Down Post Q3 Earnings
Nov 09 / Zacks.com - Paid Partner Content
 

Performance

1 month-4.86% 3 years+2.09%
3 months+1.55% 5 years+13.77%
1 year+6.99% Since inception+11.61%
Data through 11/23/2017

Quote Details

Previous close$151.23
Open day’s range150.07 – 151.48
Net asset value (NAV)151.14 (11/22/2017)
Daily volume10,598
Average volume (3 months)19,729
Data as of 3:59pm ET, 11/22/2017

Peer Comparisonvs. Health ETFs

 IHECategory
Performance 5-yr return+13.77%+16.79%
Expense Gross exp ratio0.44%1.33%
Risk 5 year sharpe ratio0.871.11
Net assets$588.9M$3.1B
Average market cap$17.5B$27.3B
Average P/E27.422.4
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson11.16%
PFE Pfizer8.81%
MRK Merck6.96%
BMY Bristol-Myers Squibb6.72%
LLY Eli Lilly and Co6.10%
AGN Allergan4.68%
ZTS Zoetis Inc4.30%
MYL Mylan NV3.80%
PRGO Perrigo Company PLC2.94%
JAZZ Jazz Pharmaceuticals PLC2.56%